Back to search

National and Kapodistrian University of Athens

Σημασία της χορήγησης προϊόντων με αυξημένες δυνατότητες (enabling products) στις ενδοαυλικές συγκεντρώσεις της αλβενδαζόλης και ανάπτυξη in vitro μεθοδολογίας για την εκτίμηση της συμπεριφοράς προϊόντων λιπόφιλων ασθενών βάσεων στον ανώτερο γαστρεντερικό αυλό κατά τη διαπεπτική περίοδο

Abstract

dc:description

Purpose: To evaluate the impact of dosage form relevant levels of a polymeric precipitation inhibitor and of lipid excipients on supersaturation of upper gastrointestinal contents with albendazole, a lipophilic weak base. To implement an in vitro methodology (Biorelevant GastroIntestinal Transfer system, BioGIT) for studying gastrointestinal transfer of highly lipophilic weak bases in the fasted upper small intestine, based on luminal dipyridamole and ketoconazole data. To evaluate the usefulness of BioGIT in predicting luminal performance of lipophilic weak bases, after administration of conventional dosage forms of albendazole and posaconazole (Noxafil®) and enabling products of albendazole and itraconazole (Sporanox®) in the fasted upper small intestine. Methods: Total albendazole amount per volume, drug concentration and equilibrium solubility in the contents of stomach and upper small intestine were evaluated after administration of 1) a suspension in water (ABZ-Control), 2) a suspension in water in which hydroxyprolylmethylcellulose E5 (HPMC E5) had been pre-dissolved (ABZ-HPMC), and 3) and 4) two contrasting designs of lipid based suspensions dispersed in water (ABZ-IIIA and ABZ-IV), on a cross-over basis to fasted healthy adults. Using BioGIT, a three compartment setup, reproducibility of the transfer process and reproduction of luminal data in humans were evaluated under conditions where solutions were present in gastric and/or duodenal compartment and by using ranitidine, dipyridamole and ketoconazole and previously published luminal data. The usefulness of BioGIT was further investigated by using suspensions of albendazole similar with those tested in the clinical study, Noxafil® suspension, Sporanox® capsules and Sporanox® solution in gastric compartment. In all cases, total drug amount per volume, drug concentration and equilibrium solubility were measured in samples collected at specific time intervals and compared with luminal data.Results: Based on total albendazole amount per volume, gastric secretions did not significantly alter volumes of bulk gastric contents during the first 40 min post administration of a glass of non-caloric water-based fluid. Αlbendazole gastric concentrations were higher than in the administered suspensions, but similar for all four formulations. Gastric emptying of albendazole particles after administration of ABZ-Control or ABZ-HPMC was slower than after administration of ABZ-IIIA or ABZ-IV. Limited, but statistically significant supersaturation of contents of upper small intestine was observed after ABZ-HPMC, ABZ-IIIA, and ABZ-IV; supersaturation was more consistent after ABZ-HPMC administration. Using BioGIT, the transfer process was performed reproducibly in all cases (RSD < 12.9%): in vitro data with dipyridamole and ketoconazole were in line with previously published luminal data in humans. Also, with BioGIT the average albendazole gastrointestinal transfer process and concentrations in upper small intestine were adequately simulated. For posaconazole and itraconazole, the % solid fractions in upper small intestine were adequately reproduced whereas based on the mean values for the area under the concentration vs. time data estimated up to 45 min post initiation of the experiment, concentrations in the duodenal compartment of BioGIT were similar to previously measured concentrations in the upper small intestine of healthy adults or they overestimated them by up to 2.5 times. In most cases, overestimation of supersaturation of contents of upper small intestine was observed due to the high variability of luminal data and/or the underestimation of the equilibrium solubility.Conclusions: Small amounts of HPMC E5 were as effective as lipid excipients in achieving supersaturation of duodenal contents with albendazole, a fast precipitating weak base, in fasted adults. Compared with the effect of HPMC E5, the effect of lipid excipients was delayed and variable. BioGIT could be useful for the evaluation of the impact of gastrointestinal transfer on concentrations in the upper intestinal lumen during the first hour, after oral administration of conventional dosage forms and enabling drug products of lipophilic weak bases.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2017

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kourentas, Alexandros
  • Κούρεντας, Αλέξανδρος

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/40960

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kourentas, Alexandros; Κούρεντας, Αλέξανδρος. Σημασία της χορήγησης προϊόντων με αυξημένες δυνατότητες (enabling products) στις ενδοαυλικές συγκεντρώσεις της αλβενδαζόλης και ανάπτυξη in vitro μεθοδολογίας για την εκτίμηση της συμπεριφοράς προϊόντων λιπόφιλων ασθενών βάσεων στον ανώτερο γαστρεντερικό αυλό κατά τη διαπεπτική περίοδο. National and Kapodistrian University of Athens, 2017. http://hdl.handle.net/10442/hedi/40960